References
- Marshall B J, Warren J R. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984; 1: 1312–1315
- Ormand J E, Tally N J. Helicobacter pylori: controversies and approach to management. Mayo Clinic Proc 1990; 65: 414–426
- Goodwin C S, Armstrong J A, Chilvers T. Transfer of Campylobacter pylori and Campylobacter mustalae to Helicobacter gen. nov. as Helicobacter pylori and Helicobacter mustalae comb, nov., respectively. Int J Syst Bacteriol 1989; 39: 397–405
- Lee A. Spiral organisms: what are they?. Scand J Gastroenterol 1991; 26(Suppl 187)9–22
- Schwarz K. Uber penetrierende magen-und jejunalgeschwure. Beitz Z Klin Chir 1890; 67: 96–128
- Osier W. Diseases of the stomach. The principles and practices of medicine. 6th ed. Appleton, New York 1905; 456–457
- Hunt R H. Spontaneous hypochiorhydria. Campylobacter pylori and gastroduodenal disease, B J Rathbone, R V Heatley. Blackwell Scientific, Oxford 1989; 176–183
- Morris A, Nicholson G. Campylobacter pyloridis causes gastritis and raised fasting gastric pH. Am J Gastroenterol 1987; 82: 192–199
- Marshall B J, Armstrong J A, McGcchie D B, Glancy R J. Attempt to fulfil Koch's postulates for pyloric Campylobacter. Med J Aust 1985; 142: 436–439
- Graham D Y, Alpert L C, Smith J L, Yoshimura H H. Latrogenic Campylobacter pylori infection is a cause of epidemic achlorhydria. Am J Gastroenterol 1988; 83: 974–980
- Ramsey E J, Cavey K V, Peterson W L. Epidemic gastritis with hypochiorhydria. Gastroenterology 1979; 76: 1449–1457
- Wiersinga W M, Tytgat G N. Clinical recovery owing to parietal cell failure in a patient with Zollinger-Ellison syndrome. Gastroenterology 1977; 73: 1413–1417
- Peterson W L, Lee E, Skogland M. The role of Campylobacter pyloridis in epidemic gastritis with hypochiorhydria. Gastroenterology 1987; 92: A1575
- Gledhill T, Leicester R J, Addis B. Epidemic hypochiorhydria. Br Med J 1985; 289: 1383–1386
- Cave D R, Vargas M. Effect of a Campylobacter pylori protein on acid secretion by parietal cells. Lancet 1989; 2: 187–189
- Defize J, Goldie J, Hunt R H. Effect of Campylobacter pylori on acid production by isolated guinea pig cells. Gut 1988; 29: A1435
- Uehara A, Okumara T, Sekiya C, Okamura K, Takasugi Y, Namiki M. Interleukin-1 inhibits the secretion of gastric acid in rats: possible involvement of prostaglandin. Biochem Biophys Res Commun 1989; 162: 1578–1584
- Robert A, Olafsson A S, Lancaster C, Zhang W. Interleukin-1 is cytoprotective, antisecretory, stimulates PGE2 synthesis by the stomach and retards gastric emptying. Life Sci 1991; 48: 123–134
- Goldschmiedt M, Karnes W E, Feldman M. Relationship between Helicobacter pylori (HP) and gastric secretion/serum gastrin concentrations in healthy humans. Gastroenterology 1990; 98: A50
- Mullin G E, Kalloo A N. Does Helicobacter pylori infection affect gastric acid secretion?. Gastroenterology 1990; 98: A92
- Levi S, Beardshall K, Haddad G, Playford R, Ghosh P, Calam J. Campylobacter pylori and duodenal ulcers: the gastrin link. Lancet 1989; 1: 1167–1168
- Montbriand J R, Appleman H D, Cotner E K, Nostrant T T, Elta G H. Treatment of Campylobacter pylori does not alter gastric acid secretion. Am J Gastroenterol 1989; 84: 1513–1516
- Levi S, Beardshall K, Swift I. Antral Helicobacter pylori, hypergastrinaemia, and duodenal ulcers: effect of eradicating the organism. Br Med J 1989; 299: 1504–1505
- McColl K EL, Fullarton O M, Nujumi A M, Macdonald A M, Dahil S, Hilditchi T E. Serum gastrin and gastric acid status one and seven months after eradication of Helicobacter pylori in duodenal ulcer patients. Gut 1990; 31: A160
- Smith J TL, Pounder R E, Nwokolo C U. Inappropriate hypergastrinaemia in asymptomatic healthy subjects infected with Helicobacter pylori. Gut 1990; 31: 522–525
- Wagner S, Gebel M, Bär W, Sculler A, Schmidt F W. The significance of Campylobacter pylori infection on 24-hour intragastric acidity in patients with gastritis and duodenal ulcer disease. Gastroenterology 1990; 98: A145
- Samloff I M, Liebman W M, Panitch N M. Serum group I pepsinogen by radioimmunoassay in control subjects and patients with peptic ulcer. Gastroenterology 1975; 30: 912–916
- Samloff I M, Varis K, Ihamäki T, Siurala M, Rotter J I. Relationship among serum pepsinogen I, and II, and gastric mucosal histology. Gastroenterology 1982; 83: 204–209
- Odera G, Vaira G, Holton J, Ainley C, Altare F, Ansaldi N. Amoxicillin plus tinidazole for Campylobacter pylori gastritis in children: assessment by serum IgG antibody, pepsinogen I, and gastrin levels. Lancet 1989; 2: 690–692
- Hengels K J, Jablonowski K, Schumacher B. Serum pepsinogens: sensitive indicators of gastritis activity. Rev Esp Enf Dig 1990; 78(Suppl 1)79–80
- Chittajallu R S, Dorian C A, McColl K EL. Serum pepsinogen I in duodenal ulcer—effect of eradication of H pylori and correlation with serum gastrin and antral gastritis. Gut 1990; 31: A1199
- Cave T R, Cave D R. A Helicobacter pylori peptide increases pepsinogen secretion from isolated rabbit gastric glands. Rev Esp Enf Dig 1990; 78(Suppl 1)52
- Halter F, Inauen W, Eigenmann F, Varga L, Koelz H R. Effect of acid inhibition on the growth of parietal cells. Scand J Gastroenterol 1986; 21(Suppl 125)9–13
- Halter F, Witzel L, Haecki W H, Olah A J, Heitz P, Varga L. Gastric secretion, the parietal cell and gastrin response to histamine H2-receptor antagonist in the rat. Proceedings of the International Symposium on histamine H2-receptor antagonists. Excerpta Medica, Amsterdam 1973; 108–111
- Fullarton G M, McLaughlan G, MacDonald A, Crean G P, McColl K EL. Rebound nocturnal hyper-secretion after four weeks treatment with an H2 receptor antagonist. Gut 1989; 30: 449–454
- Nwokolo C U, Smith J TL, Pounder R E. Rebound intragastric hyperacidity after abrupt withdrawal of histamine H2-receptor blockade. Gastroenterology 1989; 98: A369
- Isenberg J I, Grossman M I, Maxwell V, Walsh J H. Increased sensitivity to stimulation of acid secretion to pentagastrin in duodenal ulcer. J Clin Invest 1975; 55: 330–337
- Hirchowitz B I. Apparent and intrinsic sensitivity to pentagastrin of acid and pepsin secretion in peptic ulcer. Gastroenterology 1984; 86: 843–851
- Siurala M, Sipponen P, Kekki M. Campylobacter pylori in a sample of Finnish population: relations to morphology and functions of the gastric mucosa. Gut 1988; 29: 909–915
- Brooks F P. Pathophysiology of peptic ulcer: an overview. Contemporary issues in gastroenterology: peptic ulcer disease, F P Brooks, S Cohen, R D Soloway. Churchill Livingstone, New York 1985; 45–149
- Graham D Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology 1989; 96: 615–625
- Sidebotham R L, Baron J H. Hypothesis: Helicobacter, urease, mucus and gastric ulcer. Lancet 1990; 1: 193–195
- Sipponen P, Seppälä K, Äärynen M, Helske T, Kettunun P. Chronic gastritis and gastroduodenal ulcer: a case control study on risk of coexisting duodenal or gastric ulcer disease in patients with gastritis. Gut 1989; 30: 922–929
- Coghlan J G, Gilligan D, Humphries H. Campylobacter pylori and recurrence of duodenal ulcers—a 12 month follow-up study. Lancet 1987; 2: 1109–1111
- Marshall B J, Goodwin C S, Warren J R. Prospective double-blind trial of duodenal relapse after eradication of Campylobacter pylori. Lancet 1988; 2: 1437–1442
- Borody T, Noonan S, Cole P, Eaves E R, Hansky J. Recurrence of duodenal ulcer and Campylobacter pylori infection after eradication. Med J Aust 1989; 151: 431–435
- Rauws E A, Tytgat G NJ. Eradication of Helicobacter pylori cures duodenal ulcer. Lancet 1990; 1: 1233–1235
- Wyatt J I, Rathbone B J, Dixon M F, Heatley R V. Campylobacter pyloridis and acid induced gastritic metaplasia in the pathogenesis of duodenitis. J Clin Pathol 1987; 40: 841–848
- Patrick W JA, Denham D, Forrest A PM. Mucosa change in the human duodenum: a light and electron microscopic study and correlation with disease and acid secretion. Gut 1974; 15: 767–776
- Rhodes J. Experimental production of gastric epithelium in the duodenum. Gut 1964; 5: 454–458
- McCarthy D M. Helicobacter pylori infection and gastroduodenal injury by non-steroidal antiinflammatory drugs. Scand J Gastroenterol 1991; 26(Suppl 187)91–97
- Sarosiek J, Peura D A, Guerrant R L. Mucolytic effects of Helicobacter pylori. Scand J Gastroenterol 1991; 26: 47–55, Suppl 187
- Smoot D T, Mobley H LT, Chippendale G R, Lewison J F, Resau J H. Helicobacter pylori urease activity is toxic to human gastric epithelial cells. Infect Immun 1990; 58: 1992–1994
- Henessy S J, Wyatt J I, Axon A TR, Sobala G, Rathbone B J, Dixon M F. The relationship between adhesion sites and disease activity in C. pylori-associated gastritis. Gut 1990; 31: 134–138
- Fry J. Peptic ulcer: a profile. Br Med J 1964; 2: 809–812